196 related articles for article (PubMed ID: 36831869)
1. Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
Tabaee Damavandi P; Pasini F; Fanella G; Cereda GS; Mainini G; DiFrancesco JC; Trinka E; Lattanzi S
Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831869
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review.
Rossi J; Cavallieri F; Bassi MC; Biagini G; Rizzi R; Russo M; Bondavalli M; Iaccarino C; Pavesi G; Cozzi S; Giaccherini L; Najafi M; Pisanello A; Valzania F
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979629
[TBL] [Abstract][Full Text] [Related]
3. Perampanel in brain tumor-related epilepsy: Observational pilot study.
Maschio M; Zarabla A; Maialetti A; Giannarelli D; Koudriavtseva T; Villani V; Zannino S
Brain Behav; 2020 Jun; 10(6):e01612. PubMed ID: 32285623
[TBL] [Abstract][Full Text] [Related]
4. Perampanel in brain tumor and SMART-syndrome related epilepsy - A single institutional experience.
Heugenhauser J; Iglseder S; Muigg A; Kerschbaumer J; Stockhammer G; Nowosielski M; Unterberger I
J Neurol Sci; 2021 Apr; 423():117386. PubMed ID: 33706200
[TBL] [Abstract][Full Text] [Related]
5. Perampanel Confirms to Be Effective and Well-Tolerated as an Add-On Treatment in Patients With Brain Tumor-Related Epilepsy (PERADET Study).
Coppola A; Zarabla A; Maialetti A; Villani V; Koudriavtseva T; Russo E; Nozzolillo A; Sueri C; Belcastro V; Balestrini S; Ferlazzo E; Giannarelli D; Bilo L; Maschio M
Front Neurol; 2020; 11():592. PubMed ID: 32695064
[No Abstract] [Full Text] [Related]
6. Brain tumor related epilepsy: pathophysiological approaches and rational management of antiseizure medication.
Seidel S; Wehner T; Miller D; Wellmer J; Schlegel U; Grönheit W
Neurol Res Pract; 2022 Sep; 4(1):45. PubMed ID: 36059029
[TBL] [Abstract][Full Text] [Related]
7. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.
Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D
Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318
[TBL] [Abstract][Full Text] [Related]
8. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract][Full Text] [Related]
9. Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
Zwart R; Sher E; Ping X; Jin X; Sims JR; Chappell AS; Gleason SD; Hahn PJ; Gardinier K; Gernert DL; Hobbs J; Smith JL; Valli SN; Witkin JM
J Pharmacol Exp Ther; 2014 Oct; 351(1):124-33. PubMed ID: 25027316
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive perampanel for glioma-associated epilepsy.
Dunn-Pirio AM; Woodring S; Lipp E; Herndon JE; Healy P; Weant M; Randazzo D; Desjardins A; Friedman HS; Peters KB
Epilepsy Behav Case Rep; 2018; 10():114-117. PubMed ID: 30377587
[TBL] [Abstract][Full Text] [Related]
11. Perampanel attenuates epileptiform phenotype in C6 glioma.
Mayer J; Kirschstein T; Resch T; Porath K; Krause BJ; Köhling R; Lange F
Neurosci Lett; 2020 Jan; 715():134629. PubMed ID: 31734290
[TBL] [Abstract][Full Text] [Related]
12. Perampanel: What is its Place in the Management of Partial Onset Epilepsy?
Ledingham DR; Patsalos PN
Neurol Ther; 2013 Dec; 2(1-2):13-24. PubMed ID: 26000213
[TBL] [Abstract][Full Text] [Related]
13. Seizures and Tumor Progression in Glioma Patients with Uncontrollable Epilepsy Treated with Perampanel.
Izumoto S; Miyauchi M; Tasaki T; Okuda T; Nakagawa N; Nakano N; Kato A; Fujita M
Anticancer Res; 2018 Jul; 38(7):4361-4366. PubMed ID: 29970574
[TBL] [Abstract][Full Text] [Related]
14. Perampanel effects in the WAG/Rij rat model of epileptogenesis, absence epilepsy, and comorbid depressive-like behavior.
Citraro R; Leo A; Franco V; Marchiselli R; Perucca E; De Sarro G; Russo E
Epilepsia; 2017 Feb; 58(2):231-238. PubMed ID: 27988935
[TBL] [Abstract][Full Text] [Related]
15. AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives.
Di Bonaventura C; Labate A; Maschio M; Meletti S; Russo E
Expert Opin Pharmacother; 2017 Nov; 18(16):1751-1764. PubMed ID: 29023170
[TBL] [Abstract][Full Text] [Related]
16. Perampanel: Does it have broad-spectrum potential?
Potschka H; Trinka E
Epilepsia; 2019 Mar; 60 Suppl 1():22-36. PubMed ID: 29953584
[TBL] [Abstract][Full Text] [Related]
17. Perampanel Add-on to Standard Radiochemotherapy
Lange F; Hartung J; Liebelt C; Boisserée J; Resch T; Porath K; Hörnschemeyer MF; Reichart G; Sellmann T; Neubert V; Kriesen S; Hildebrandt G; Schültke E; Köhling R; Kirschstein T
Front Neurosci; 2020; 14():598266. PubMed ID: 33328869
[TBL] [Abstract][Full Text] [Related]
18. The AMPA receptor antagonist perampanel suppresses epileptic activity in human focal cortical dysplasia.
Brito da Silva A; Pennifold J; Henley B; Chatterjee K; Bateman D; Whittaker RW; Joshi A; Kumar H; Nicholson C; Baker MR; Greenhill SD; Walsh R; Seri S; Jones RSG; Woodhall GL; Cunningham MO
Epilepsia Open; 2022 Sep; 7(3):488-495. PubMed ID: 34653311
[TBL] [Abstract][Full Text] [Related]
19. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.
Lange F; Hörnschemeyer J; Kirschstein T
Cells; 2021 May; 10(5):. PubMed ID: 34067762
[TBL] [Abstract][Full Text] [Related]
20. Levetiracetam Prophylaxis Therapy for Brain Tumor-Related Epilepsy (BTRE) Is Associated With a Higher Psychiatric Burden.
Dono F; Consoli S; Evangelista G; Ricci A; Russo M; Carrarini C; Di Iorio A; Bonanni L; Anzellotti F; Onofrj M; Sensi SL
Front Neurol; 2021; 12():806839. PubMed ID: 35087476
[No Abstract] [Full Text] [Related]
[Next] [New Search]
